studi
specif
sequenc
within
three
gene
footandmouth
diseas
viru
fmdv
genom
determin
effect
rnai
target
sequenc
highli
conserv
among
differ
serotyp
virus
base
sequenc
analysi
small
interf
rna
sirna
express
plasmid
construct
express
sirna
target
respect
antivir
potenti
sirna
variou
fmdv
isol
investig
babi
hamster
kidney
cell
suckl
mice
result
show
sirna
inhibit
viru
yield
differ
fmdv
isol
serotyp
serotyp
asia
h
post
infect
cell
compar
control
cell
suckl
mice
delay
death
mice
twenti
percent
anim
receiv
singl
sirna
dose
surviv
day
post
infect
serotyp
serotyp
asia
use
attenu
salmonella
choleraesui
vaccin
strain
carri
plasmid
express
sirna
direct
polymeras
gene
fmdv
use
guinea
pig
evalu
inhibitori
effect
recombin
cho
cho
fmdv
infect
result
show
guinea
pig
inocul
cfu
cho
challeng
h
later
id
homolog
fmdv
protect
also
measur
antivir
activ
cho
swine
result
indic
anim
treat
cfu
cho
protect
day
footandmouth
diseas
viru
rna
interfer
salmonella
choleraesui
conserv
sequenc
swine
short
interf
rna
sirna
small
doublestrand
rna
molecul
direct
degrad
complementari
messeng
rna
via
cellular
process
known
rna
interfer
wide
believ
rna
interfer
evolutionarili
conserv
mechan
within
eukaryot
function
includ
endogen
gene
regul
viral
defens
mainten
genom
stabil
rapid
specif
rnai
technolog
could
complement
improv
tradit
tool
avail
control
import
anim
pathogen
footandmouth
diseas
fmd
extrem
contagi
diseas
affect
speci
clovenhoof
anim
includ
open
access
articl
distribut
term
creativ
common
attributionnoncommerci
licens
http
permit
unrestrict
use
distribut
reproduct
noncommerci
medium
provid
origin
work
properli
cite
cattl
swine
livestock
diseas
known
five
centuri
caus
agent
fmd
viru
fmdv
belong
genu
aphthoviru
famili
picornavirida
fmdv
genom
compos
positivesens
singlestrand
rna
molecul
nucleotid
contain
uniqu
open
read
frame
like
rna
virus
fmdv
antigen
variabl
undergo
rapid
mutat
seven
distinguish
serolog
type
fmdv
name
c
asia
current
fmd
vaccin
base
inactiv
viru
effect
prevent
diseas
carri
risk
incomplet
inactiv
viral
escap
vaccin
product
laboratori
fail
induc
immun
respons
short
period
thu
develop
emerg
antivir
strategi
necessari
order
stem
outbreak
fmd
antivir
technolog
rnai
alreadi
wide
research
use
fmdv
howev
establish
rnai
viabl
approach
prevent
fmdv
requir
resolv
least
one
major
issu
high
genet
variabl
fmd
virus
rnai
direct
toward
specif
gene
sequenc
certain
fmdv
strain
may
face
risk
especi
event
emerg
fmd
outbreak
inform
serotyp
genotyp
isol
pathogen
would
avail
earli
protect
need
therefor
may
necessari
design
sever
sirna
focu
conserv
region
viral
genom
previous
show
sirna
gener
vitro
effect
inhibit
replic
fmdv
either
specif
crossinhibitori
manner
anoth
crucial
issu
need
address
optim
vector
deliveri
sirnaexpress
cassett
chen
et
al
demonstr
treatment
recombin
replicationdefect
human
adenoviru
type
express
shorthairpin
rna
significantli
reduc
suscept
guinea
pig
swine
fmdv
infect
howev
adenoviru
noncod
rna
abl
inhibit
biogenesi
sirna
microrna
find
suggest
novel
sirna
deliveri
system
would
necessari
salmonella
member
enter
bacilli
one
sever
etiolog
agent
foodborn
diseas
wide
accept
recombin
live
vaccin
use
attenu
salmonella
vector
deliv
passeng
antigen
induc
immun
respons
salmonella
infect
also
passeng
pathogen
infect
liveattenu
salmonella
shown
deliv
dna
vaccin
earli
fang
et
al
screen
attenu
salmonella
choleraesui
licens
live
vaccin
swine
paratyphoid
liu
et
al
prove
attenu
choleraesui
carri
oral
dna
vaccin
induc
immun
respons
fmdv
present
studi
construct
sever
sirnaexpress
plasmid
target
conserv
sequenc
within
code
region
viral
polymeras
protein
capsid
protein
nonstructur
np
protein
fmdv
genom
plasmid
inhibit
sever
isol
serotyp
serotyp
asia
fmdv
babi
hamster
kidney
cell
suckl
mice
furthermor
report
sirna
direct
polymeras
protein
fmdv
deliv
attenu
choleraesui
capabl
inhibit
viru
replic
guinea
pig
swine
attenu
vaccin
strain
choleraesui
obtain
nanj
biolog
pharmaceut
co
ltd
attenu
salmonella
typhimurium
kindli
provid
prof
aoquan
wang
institut
microbiolog
chines
academi
scienc
plasmid
mous
promot
p
construct
maintain
laboratori
suckl
mice
day
old
weigh
g
maintain
biopharmaci
jinyu
group
co
ltd
male
femal
guinea
pig
weigh
g
larg
white
swine
vet
re
weigh
kg
use
perform
viral
challeng
anim
hous
diseasesecur
isol
facil
fmdvfree
area
previou
fmd
contact
confirm
absenc
detect
antifmdv
antibodi
sera
human
kidney
cell
use
grow
recombin
replicationdefect
human
adenovirus
determin
viru
titer
cell
use
grow
fmdvand
determin
viru
infect
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
ph
cultur
incub
co
two
fmdv
isol
serotyp
genbank
access
number
cha
genbank
access
number
two
fmdv
isol
serotyp
asia
genbank
access
number
jiangsu
genbank
access
number
use
viral
challeng
recombin
replicationdefect
human
adenovirus
construct
maintain
laboratori
express
sirna
target
fmdv
sequenc
correspond
nucleotid
nt
control
nonspecif
effect
express
sirna
correspond
nt
bgalactosidas
gene
escherichia
coli
homolog
genom
confirm
sequenc
analysi
sequenc
encod
fmdv
sirna
gaggctatcctctc
ctttgcacgccgtgggaccatacaggagaag
sens
encod
e
coli
bgalactosidasespecif
sirna
gagtgtgatcatctggtcgctgggga
atgaatcaggccacggcgctaatcacgacgc
sens
gener
strategi
construct
sirnaexpress
plasmid
invert
repeat
target
sequenc
clone
plasmid
ecorihindiii
site
control
promot
termin
signal
thymidin
plasmid
contain
invert
repeat
correspond
nucleotid
sequenc
fmdv
genom
describ
neg
control
nonspecif
effect
plasmid
placz
contain
invert
repeat
nt
nt
respect
homolog
fmdv
genom
confirm
sequenc
analysi
target
interest
essenti
life
cycl
fmdv
rel
conserv
nucleotid
sequenc
refer
sequenc
conserv
region
fmdv
genom
obtain
nation
center
biotechnolog
inform
ncbi
websit
compar
nucleotid
nt
blast
sequenc
correspond
nt
gene
sequenc
gag
gctatcctctcctttgcacgccgtgggaccat
correspond
nt
gene
sequenc
tcaggcaa
cactggaagcatcattaacaactactacatgc
correspond
nt
gene
sequenc
acaactacta
correspond
nt
gene
sequenc
correspond
nt
gene
viru
infect
determin
serial
dilut
sampl
cell
grown
plate
viru
titer
calcul
tissu
cultur
infect
dose
reedmuench
method
viral
suspens
titrat
tcid
per
ml
use
viral
challeng
cell
seed
plate
dmem
h
transfect
cell
confluent
transient
transfect
lg
singl
plasmid
express
specif
sirna
five
hour
transfect
transfect
complex
remov
cell
wash
twice
dmem
tcid
fmdv
per
ml
ad
well
h
adsorpt
inoculum
remov
cell
wash
twice
dmem
infect
proceed
dmem
supplement
fetal
bovin
serum
cell
supernat
collect
design
time
point
viru
titer
determin
three
time
cell
statist
analysi
perform
microsoft
excel
program
microsoft
redmond
wa
usa
suckl
mice
group
subcutan
inject
neck
lg
plasmid
phosphatebuff
salin
pb
h
suckl
mice
challeng
ld
fmdv
per
ml
via
subcutan
inject
neck
near
site
receiv
inject
dna
mice
observ
day
postchalleng
dpc
statist
analysi
perform
log
rank
test
order
prepar
recombin
cho
placz
cho
cho
attenu
typhimurium
intermedi
host
cell
first
transform
plasmid
placz
use
standard
cacl
method
plasmid
extract
transfer
termin
host
cellattenu
choleraesui
electropor
prepar
cell
electropor
follow
cell
cultur
ml
lb
medium
rpm
overnight
inocul
ml
liquid
lb
medium
vv
shake
rpm
bacteria
grown
optic
densiti
od
chill
collect
centrifug
rpm
min
cell
wash
glycerol
three
time
cell
resuspend
glycerol
concentr
cellsml
frozen
dri
ice
store
aliquot
cell
thaw
use
transform
one
microgram
dna
control
setup
dna
mix
cold
cell
suspens
transfer
chill
cuvett
transform
carri
biorad
gene
pulser
kv
lf
x
transform
compet
cell
transfer
tube
media
ad
prior
incub
cultur
h
rpm
cultur
transfer
onto
solid
lb
medium
contain
llml
ampicillin
recombin
bacteria
identifi
via
pcr
presenc
recombin
plasmid
confirm
digest
xhoi
serolog
characterist
recombin
choleraesui
rs
cho
test
use
congreg
reaction
glass
plate
confirm
immunogen
live
bacteria
prepar
cultur
cell
ml
liquid
lb
medium
h
follow
inocul
ml
cultur
ml
liquid
lb
medium
produc
cfuml
live
bacteria
count
perform
serial
dilut
cultur
follow
spread
plate
serotyp
fmdv
strain
hkn
passag
five
time
suckl
mice
use
challeng
guinea
pig
viru
passag
three
time
swine
use
swine
experi
virus
titrat
guinea
pig
swine
dose
fmdv
use
determin
four
serial
dilut
viru
ie
pb
guinea
pig
group
anim
inocul
intraderm
left
rear
foot
ml
serial
dilut
virus
accord
method
describ
chen
et
al
swine
group
inocul
neck
region
intramuscular
inject
anim
ml
serial
dilut
viru
anim
monitor
major
clinic
sign
fmd
appear
vesicl
mouth
feet
anim
infect
dose
id
estim
use
reedmuench
method
statist
analysi
perform
log
rank
test
guinea
pig
sever
group
five
inocul
intramuscular
inject
cfu
recombin
attenu
choleraesui
ml
salin
thirtysix
hour
inocul
fmdv
challeng
carri
via
intraderm
inject
anim
ml
guinea
pig
infecti
dose
id
left
rear
foot
done
viru
titrat
parallel
experi
anim
treat
pfu
challeng
h
later
id
test
whether
combin
inocul
rs
cho
protect
anim
group
inject
intramuscularli
mixtur
cfu
pfu
respect
h
challeng
id
eighteen
swine
divid
group
anim
anim
group
cohous
separ
room
group
inocul
via
intramuscular
inject
neck
area
group
mock
control
group
inocul
ml
salin
neg
control
group
inocul
cfu
choleraesui
lacz
cho
ml
salin
respect
group
inocul
cfu
cho
ml
salin
group
treat
high
dose
cho
contain
cfu
ml
salin
h
anim
challeng
via
intramuscular
inject
id
ml
pb
neck
area
avoid
overexposur
challeng
viru
anim
develop
diseas
move
anoth
room
observ
proceed
challeng
anim
examin
daili
clinic
sign
fmd
includ
increas
bodi
temperatur
appear
vesicl
mouth
feet
lesion
score
determin
variou
time
point
postchalleng
determin
number
digit
plu
mouth
vesicl
anim
observ
termin
day
postchalleng
anim
human
kill
blood
serum
sampl
collect
day
challeng
swine
experi
assess
neutral
antibodi
respons
swine
plaqu
reduct
neutral
assay
perform
describ
previous
neutral
titer
report
highest
serum
dilut
caus
reduct
number
hkn
plaqu
cell
presenc
antibodi
viral
ns
protein
fmdv
sera
detect
use
solidphas
block
enzymelink
immunosorb
assay
spbelisa
accord
procedur
describ
chenard
et
al
briefli
elisa
microtit
test
plate
coat
overnight
recombin
antigen
express
e
coli
five
wash
pb
contain
tween
pbst
well
plate
fill
test
refer
serum
dilut
pbst
incub
min
serum
remov
well
plate
wash
describ
rewash
immunoglobulinhorseradish
peroxidas
conjug
ad
incub
proceed
min
conjug
remov
well
plate
wash
commerci
readytous
tetramethyl
benzidin
chromogen
substrat
ad
plate
incub
min
reaction
stop
ad
h
per
well
od
nm
measur
use
elisa
reader
sera
consid
posit
od
reduc
compar
standard
neg
serum
correct
background
signal
subtract
od
high
posit
refer
serum
statist
analysi
perform
microsoft
excel
program
test
antivir
activ
sirna
cell
cultur
plate
transfect
sirnaexpress
plasmid
individu
control
cell
either
treat
treat
plasmid
placz
h
cell
infect
tcid
ynb
cell
observ
continu
microscop
microscopi
examin
reveal
cell
treat
delay
cytopath
effect
cpe
develop
challeng
either
serotyp
asia
fmdv
howev
control
cell
either
blank
transfect
control
plasmid
show
extens
cpe
within
h
post
infect
pi
furthermor
investig
effect
plasmidmedi
rnai
fmdv
replic
measur
tcid
supernat
lyse
cell
collect
h
viral
challeng
consist
observ
show
wider
crossinhibitori
effect
plasmid
plasmid
inhibit
fmdv
isol
fig
supernat
tcid
cell
treat
reduc
h
post
infect
fig
compar
control
group
examin
antifmdv
potenti
vivo
challeng
suckl
mice
pretreat
subcutan
inject
plasmid
fmdv
strain
pbstreat
mice
die
within
h
either
challeng
fig
anim
treat
control
plasmid
also
protect
although
death
group
delay
slightli
p
p
fig
challeng
experi
anim
treat
either
protect
fig
differ
surviv
mice
treat
either
pb
control
statist
signific
p
case
challeng
mice
treat
mice
treat
surviv
viral
challeng
ld
fig
signific
differ
mous
surviv
seen
mice
treat
either
control
p
furthermor
challeng
assay
time
death
mice
delay
h
group
treat
fmdvspecif
sirnaexpress
plasmid
compar
control
group
data
obtain
cell
cultur
suckl
mice
assay
demonstr
sirna
target
conserv
region
fmdv
genom
could
effect
fmdv
either
specif
crossinhibitori
manner
potenti
rnai
antivir
strategi
fmdv
relev
anim
system
great
interest
fact
attenu
salmonella
wide
use
dna
vaccin
vector
made
us
choos
vector
sirna
deliveri
test
antifmdv
potenti
rs
cho
challeng
guinea
pig
pretreat
intramuscular
inject
rs
cho
construct
fmdv
salinetr
anim
develop
major
clinic
sign
fmd
appear
vesicl
feet
within
h
challeng
tab
guinea
pig
treat
placz
cho
protect
though
clinic
sign
delay
anim
shown
tabl
howev
guinea
pig
pretreat
cfu
cho
challeng
id
develop
none
clinic
sign
vesicl
high
fever
result
indic
chodeliv
sirna
exert
vivo
inhibitori
activ
fmdv
guinea
pig
evalu
potenti
treatment
fmdvspecif
rs
cho
mixtur
guinea
pig
three
five
anim
group
treat
mixtur
complet
protect
determin
absenc
vesicl
feet
tab
signific
increas
antivir
effect
achiev
group
compar
group
treat
cho
alon
tab
indic
simpl
combin
two
vector
could
improv
protect
anim
base
experi
guinea
pig
evalu
antivir
activ
cho
swine
anim
intramuscularli
inocul
cfu
cho
challeng
h
later
id
salinetr
swine
develop
acut
sign
fmd
includ
vesicl
fever
fig
anim
vesicl
earli
dpc
symptom
extraordinarili
sever
comparison
group
anim
inocul
either
placz
cho
cho
show
sign
signific
antivir
activ
fig
howev
cho
confer
mark
antivir
activ
could
seen
day
observ
fig
anim
group
develop
fever
vesicl
observ
period
although
anim
develop
vesicl
fewer
develop
much
later
anoth
group
inocul
cfu
cho
none
anim
protect
fig
anim
show
delay
diseas
onset
milder
diseas
control
anim
serum
sampl
collect
dpc
test
presenc
neutral
antibodi
antibodi
viral
ns
protein
fmdv
anim
mark
fmdvspecif
antibodi
dpc
includ
antibodi
tab
ii
anim
control
group
treat
salin
cho
placz
cho
develop
high
neutral
antibodi
respons
dpc
suggest
anim
expos
larg
amount
fmdv
tab
ii
low
neutral
antibodi
respons
detect
dpc
anim
inocul
cho
suggest
anim
effect
suppress
viru
replic
key
distinguish
featur
infect
anim
induct
antibodi
polyprotein
fmdv
use
lpbelisa
show
anim
develop
fmd
significantli
higher
level
antibodi
compar
diseasefre
anim
tab
ii
result
serolog
analysi
consist
observ
clinic
sign
strategi
aim
confer
rapid
effici
protect
fmdv
face
one
main
challeng
factor
rapid
acut
infect
caus
viru
make
absenc
suffici
amount
antibodi
interf
factor
essenti
protect
tradit
emerg
vaccin
base
viru
inactiv
could
effect
prevent
diseas
within
day
postvaccin
due
critic
role
innat
immun
defens
howev
sign
diseas
appear
earli
day
postexposur
thu
necessari
develop
antivir
strategi
capabl
induc
earli
protect
face
outbreak
threaten
spread
wide
recent
sever
group
demonstr
rnai
potenti
use
therapeut
tabl
prophylact
mechan
fmdv
howev
effect
rna
virus
fmdv
highli
antigen
variabl
sirna
must
target
conserv
region
provid
evid
sirna
target
conserv
region
fmdv
genom
could
effect
inhibit
viru
replic
multipl
fmdv
serotyp
studi
three
gene
name
select
target
three
reason
first
well
known
differ
sirna
differ
effici
induc
rnai
second
protein
encod
gene
essenti
function
differ
phase
viral
replic
cycl
rnadepend
rna
polymeras
key
enzym
viral
rna
replic
structur
protein
locat
insid
matur
viru
particl
involv
convers
provirion
matur
virion
involv
membran
rearrang
requir
viral
rna
replic
capsid
assembl
third
compar
report
fmdv
isol
serotyp
serotyp
asia
analysi
show
sequenc
region
rel
conserv
differ
fmdv
serotyp
effici
deliveri
sirna
cell
organ
vivo
remain
major
bottleneck
antivir
therapi
number
method
deliv
sirna
vivo
test
liposom
formul
gener
use
simpl
intranas
administr
nake
sirna
shown
effect
respiratori
virus
chen
et
al
use
adenovirus
vector
deliveri
duplex
rna
target
tissu
total
rna
extract
five
tissu
oropharynx
lung
liver
muscl
epidermi
foot
guinea
pig
treat
assay
gfp
mrna
vast
major
found
liver
clovenhoof
anim
oropharynx
identifi
major
site
fmdv
replic
acut
persist
infect
brown
et
al
indic
fmdv
rna
local
tonsil
pharynx
tracheobronchi
lymph
node
differ
tissu
distribut
fmdv
probabl
relat
antivir
activ
vivo
overal
goal
find
sirna
vector
spread
similar
infect
transmiss
tract
fmdv
attenu
salmonella
becom
popular
express
foreign
antigen
vaccin
strain
deliveri
vector
dna
vaccin
gray
et
al
found
choleraesui
often
recov
lymph
node
tonsil
lung
alimentari
tract
swine
inocul
choleraesui
studi
arous
interest
evalu
potenti
salmonella
vector
sirna
deliveri
found
guinea
pig
complet
protect
inocul
cfu
cho
rs
cho
also
confer
mark
antivir
activ
swine
surprisingli
antivir
potenti
rnai
evid
impair
anim
treat
high
dose
rs
cho
srinivasan
et
al
demonstr
variat
initi
dose
infect
salmonella
profound
effect
respons
salmonella
flagellinspecif
cell
vivo
lowdos
infect
could
evad
salmonella
flagellinspecif
cell
activ
complet
mercado
et
al
report
dilut
bacteri
challeng
dose
significantli
alter
size
kinet
listeria
llo
specif
cell
respons
lowdos
effect
may
repres
gener
mechan
increas
virul
immun
evas
could
probabl
make
lower
dose
salmonella
effici
vector
carri
sirna
lack
use
deliveri
rnai
sever
group
evalu
antivir
potenti
combin
inocul
rs
cho
guinea
pig
result
indic
signific
increas
antivir
effect
achiev
group
treat
mixtur
compar
group
treat
cho
alon
kim
et
al
attempt
improv
antivir
effect
use
mixtur
two
adenoviru
construct
give
two
inject
shrna
prior
fmdv
challeng
give
inject
fmdv
challeng
high
surviv
rate
maintain
treatment
adenovirus
postchalleng
result
could
encourag
us
seek
effici
method
treatment
conclus
licens
strain
choleraesui
potenti
rnai
deliveri
system
strain
safe
swine
rel
inexpens
manufactur
well
suit
largescal
administr
howev
remain
unclear
attenu
salmonella
deliv
sirna
vivo
futur
studi
relev
cytokin
distribut
sirna
necessari
examin
issu
detail
